According to the report published by Visiongain, the Zika Virus Testing market was valued at approximately USD xx million in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030. The virus Zika is a flavivirus which has Zika virus disease caused by infection. The infected Aedes species mosquitoes primarily transmit the virus. Nevertheless, Zika virus can be passed on to his or her sexual partner by an infected man. Although Zika virus infection typically is asymptomatic or induces moderate disease, a risk of Zika virus and developmental microcephaly as well as other serious brain defects occur. Molecular and serological testing are included in diagnostic tests to determine Zika virus infection. This policy outlines the requirements of the medical need for diagnostic tests.
Zika virus, more frequently spread by Ae, is mainly the bites of contaminated Aedes mosquitoes. Aegypti and perhaps Ae. Ae. Mosquitoes of albopictus. 3 Zika virus has been documented for sexually transmitted from males to their sexual partners, from 4 to females to male sexual partners. 14 The hazard assessment of Zika virus is actually of unknown interest, unless the two spouses become symptomatic and a person decides to marry, because the virus has little understanding for male genitourinary tract loss.
One of the major trends in increasing market growth is the participation of international organisations, such as UNICEF, and national governments in low-income developed countries. Moreover, a 2016 outbreak of Zika virus (ZIKV) has contributed to enormous traction of the market. In Brazil, between 2015 and 2016, there were about 1 950 cases of microcephaly in this region. A threat to public health was declared to be zika virus in October 2016, after a correlation was found between ZIKV and neurological birth defects in Brazil. This link between microcephaly in newborn babies with ZIKV has increased surveillance efforts and a demand for diagnostics since the end of the 2016 Zika epidemic. CDC reports that 5,264 individuals have been Zika infected in the U.S., where more than 1,700 pregnant women have been identified with Zika positive and 58 babies have born with birth defects.
A large part of the disease-related transmission in certain countries contributed to Zika virus in 2016. In the United States, 4,830 Zika-related cases have been reported, representing 94.0% of the overall cases for 2016. In addition to symptomatic cases testing to prevent transmission of diseases that drive the demand for ZIKV diagnostics, blood testing for Zika infection has therefore also been incorporated. In the US and Singapore, blood donations to Zika virus infections will primarily be diagnosed.
Organizations like the WHO, the PAHO and UNICEF have launched social approaches to Zika as a global impact. Such methods vary from therapeutic structures to stocks for clinical care. In addition to supporting preventive and prophylactic Zika virus studies, the organizations focus on potential emergency diagnostics, which help the market’s expansion.
Development of POC diagnostics which produce fast results can shape the market’s future. UNICEF and PAHO are proposing early buy-out agreements (APC) to facilitate fast diagnostics for the prevention of zika viruses. These APCs cover endemic areas of ZIKV that threaten potential outbreaks and require fast diagnostic testing. UNICEF has sealed contracts for the supply of their valid 2019 Zika detection tests by Chembio Diagnostics Systems, Inc. and SD Biosensors, Inc.
In 2016, NAAT and serological testing were both diagnose-test types, and held nearly equal market shares, with both tests performed on most subjects to confirm ZIKV infection during the epidemic. The NAAT segment, however, has a small margin as it is more widely available and can be used with economic efficiency for large-scale surveillance. With the conclusion of the outbreak at the start of 2017, both severe and late stage ZIKV disease began to take priority over NAAT. Furthermore, new fast serologic identification diagnostics also provide shorter turnaround times and differentiated Zika diagnosis from other flaviviruses.
Why you should buy Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis by Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing) and Geography, with Profiles of Leading Companies
What is the future of the Zika Virus Testing market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 156 page report you will receive the following key information –
• View Zika Virus Testing market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Zika Virus Testing revenue forecast
– Zika Virus Testing connections forecast
• Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Zika Virus Testing market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Zika Virus Testing sector
• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Zika Virus Testing industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Zika Virus Testing submarkets with individual forecasts and analysis from 2020-2030.
– Diagnostic Test Type submarket forecast 2020-2030
– End User submarket forecast 2020-2030
– submarket forecast 2020-2030
• Learn about the market prospects for the leading Zika Virus Testing market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Zika Virus Testing revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Diagnostic Test Type Revenue Forecast 2020-2030
– Molecular Test revenue forecast 2020-2030
– Serologic Test revenue forecast 2020-2030
– Plaque Reduction Neutralization Test revenue forecast 2020-2030
– Others revenue forecast 2020-2030
– End User Revenue Forecast 2020-2030
– Diagnostic Laboratory revenue forecast 2020-2030
– Hospital revenue forecast 2020-2030
– Clinics revenue forecast 2020-2030
– Academic Institutes revenue forecast 2020-2030
– Other revenue forecast 2020-2030
• Understand the prospects for the 4 regional and the leading 12 national Zika Virus Testing markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Zika Virus Testing companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
• Explore the factors affecting Zika Virus Testing product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
• Identify who the leading companies are in the Zika Virus Testing industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Zika Virus Testing companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Zika Virus Testing Market
Luminex Corporation
Primerdesign Ltd
Quest Diagnostics
ARUP Laboratories
Altona Diagnostics GmbH
Chembio Diagnostic Systems Inc.
F. Hoffmann-La Roche Ltd
Fast Track Diagnostics Ltd
Genekam
Simens
Abbott Molecular
Discover Information found nowhere else in this independent assessment of the Zika Virus Testing market
The Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis By Diagnostic Test Type, By End User, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Zika Virus Testing sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis By Diagnostic Test Type, By End User, By and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Zika Virus Testing market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Zika Virus Testing sector and find out what its future market prospects are.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis by Diagnostic Test Type, by End User, and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Zika Virus Testing Market Definition
1.2 Global Zika Virus Testing Market Overview
1.3 Global Zika Virus Testing Market Segmentation
1.4 Research Scope of Zika Virus Testing in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Zika Virus Testing Systems Market
2.1 Market Definition
2.2 Industry Outlook
2.3 Value Chain Analysis
2.4 Industry Structure
2.5 Current Status & Trends
2.6 Demand & Supply Analysis
2.7 Trade Analysis
2.8 Price Trend Analysis
3. Global Zika Virus Testing Market Analysis
3.1 PEST Analysis of the Zika Virus Testing Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Zika Virus Testing Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.2 Supplier Power
3.9.3 Buyer Power
3.9.4 Threat of Substitute
3.9.5 Threat of New Entrant
4. Zika Virus Testing: Global Market Analysis by Segments
4.1 Global Zika Virus Testing Market Forecast, by Diagnostic Test Type 2020-2030
4.1.1 Diagnostic Test Type Overview
4.1.2 Molecular Test Market Forecast, 2020-2030
4.1.3 Serologic Test Market Forecast, 2020-2030
4.1.4 Plaque Reduction Neutralization Test Market Forecast, 2020-2030
4.1.5 Other Diagnostic Test Type Market Forecast, 2020-2030
4.2 Global Zika Virus Testing Market Forecast, by End User 2020-2030
4.2.1 End User Overview
4.2.2 Diagnostic Laboratory Market Forecast, 2020-2030
4.2.3 Hospital Market Forecast, 2020-2030
4.2.4 Clinics Market Forecast, 2020-2030
4.2.5 Academic Institutes Market Forecast, 2020-2030
4.2.6 Other End User Market Forecast, 2020-2030
5. Leading Regions in Zika Virus Testing Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Zika Virus Testing Market Forecast, 2020-2030
5.2.1 North America Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
5.2.2 North America Zika Virus Testing Submarket, By End User Forecast 2020-2030
5.2.3 North America Zika Virus Testing Submarket, By Forecast 2020-2030
5.2.4 North America Zika Virus Testing Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Zika Virus Testing Market, Forecast 2020-2030
5.2.4.2 Canada Zika Virus Testing Market, Forecast 2020-2030
5.2.4.3 Mexico Zika Virus Testing Market, Forecast 2020-2030
5.3 Europe Zika Virus Testing Market Forecast, 2020-2030
5.3.1 Europe Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
5.3.2 Europe Zika Virus Testing Submarket, By End User Forecast 2020-2030
5.3.3 Europe Zika Virus Testing Submarket, By Forecast 2020-2030
5.3.4 Europe Zika Virus Testing Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Zika Virus Testing Market, Forecast 2020-2030
5.3.4.2 Germany Zika Virus Testing Market, Forecast 2020-2030
5.3.4.3 France Zika Virus Testing Market, Forecast 2020-2030
5.3.4.4 Italy Zika Virus Testing Market, Forecast 2020-2030
5.3.4.5 Spain Zika Virus Testing Market, Forecast 2020-2030
5.3.4.6 The Netherlands Zika Virus Testing Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Zika Virus Testing Market, Forecast 2020-2030
5.4 Asia-Pacific Zika Virus Testing Market Forecast, 2020-2030
5.4.1 Asia-Pacific Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
5.4.2 Asia-Pacific Zika Virus Testing Submarket, By End User Forecast 2020-2030
5.4.3 Asia-Pacific Zika Virus Testing Submarket, By Forecast 2020-2030
5.4.4 Asia-Pacific Zika Virus Testing Submarket, By Country Forecast 2020-2030
5.4.4.1 China Zika Virus Testing Market, Forecast 2020-2030
5.4.4.2 India Zika Virus Testing Market, Forecast 2020-2030
5.4.4.3 Japan Zika Virus Testing Market, Forecast 2020-2030
5.4.4.4 Korea Zika Virus Testing Market, Forecast 2020-2030
5.4.4.5 Indonesia Zika Virus Testing Market, Forecast 2020-2030
5.4.4.6 Australia Zika Virus Testing Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Zika Virus Testing Market, Forecast 2020-2030
5.5 Rest of World Zika Virus Testing Market Forecast, 2020-2030
5.5.1 Rest of World Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
5.5.2 Rest of World Zika Virus Testing Submarket, By End User Forecast 2020-2030
5.5.3 Rest of World Zika Virus Testing Submarket, By Forecast 2020-2030
6. Leading Companies in The Zika Virus Testing Market
6.1 Luminex Corporation
6.1.1 Luminex Corporation Overview
6.1.2 Analysis of Luminex Corporation Products and Services
6.1.3 Luminex Corporation Primary Market Competitors 2019
6.1.4 Luminex Corporation Key Developments
6.2 Primerdesign Ltd
6.2.1 Primerdesign Ltd Company Overview
6.2.2 Analysis of Primerdesign Ltd Products and Services
6.2.3 Primerdesign Ltd Primary Market Competitors 2019
6.2.4 Primerdesign Ltd Key Developments
6.3 Quest Diagnostics
6.3.1 Quest Diagnostics Company Overview
6.3.2 Analysis of Quest Diagnostics Products and Services
6.3.3 Quest Diagnostics Primary Market Competitors 2019
6.3.4 Quest Diagnostics Key Developments
6.4 ARUP Laboratories
6.4.1 ARUP Laboratories Company Overview
6.4.2 Analysis of ARUP Laboratories Products and Services
6.4.3 ARUP Laboratories Primary Market Competitors 2019
6.4.4 ARUP Laboratories Key Developments
6.5 Altona Diagnostics GmbH
6.5.1 Altona Diagnostics GmbH Company Overview
6.5.2 Analysis of Altona Diagnostics GmbH Products and Services
6.5.3 Altona Diagnostics GmbH Primary Market Competitors 2019
6.5.4 Altona Diagnostics GmbH Key Developments
6.6 Chembio Diagnostic Systems Inc.
6.6.1 Chembio Diagnostic Systems Inc. Company Overview
6.6.2 Analysis of Chembio Diagnostic Systems Inc. Products and Services
6.6.3 Chembio Diagnostic Systems Inc. Primary Market Competitors 2019
6.6.4 Chembio Diagnostic Systems Inc. Key Developments
6.7 F. Hoffmann-La Roche Ltd
6.6.1 F. Hoffmann-La Roche Ltd Company Overview
6.6.2 Analysis of F. Hoffmann-La Roche Ltd Products and Services
6.6.3 F. Hoffmann-La Roche Ltd Primary Market Competitors 2019
6.6.4 F. Hoffmann-La Roche Ltd Key Developments
6.8 Fast Track Diagnostics Ltd
6.8.1 Fast Track Diagnostics Ltd Company Overview
6.8.2 Analysis of Fast Track Diagnostics Ltd Products and Services
6.8.3 Fast Track Diagnostics Ltd Primary Market Competitors 2019
6.8.4 Fast Track Diagnostics Ltd Key Developments
6.9 Genekam
6.9.1 Genekam Company Overview
6.9.2 Analysis of Genekam Products and Services
6.9.3 Genekam Primary Market Competitors 2019
6.9.4 Genekam Key Developments
6.10 Simens
6.10.1 Simens Company Overview
6.10.2 Analysis of Simens Products and Services
6.10.3 Simens Primary Market Competitors 2019
6.10.4 Simens Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Zika Virus Testing Market Segmentation
Figure 2.1 Zika Virus Testing Value Chain Analysis
Figure 3.1 Zika Virus Testing Supply-Demand Analysis
Figure 4.1 Global Zika Virus Testing Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Zika Virus Testing Market Forecast 2020-2030
Figure 4.3 Global Zika Virus Testing Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Zika Virus Testing Market By Diagnostic Test Type Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.19 Global Zika Virus Testing by Submarket By Diagnostic Test Type Forecast 2020-2030 ($ million)
Figure 4.20 Global Zika Virus Testing Market, by Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.21 Zika Virus Testing Market, By End User Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Zika Virus Testing Market, By System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Zika Virus Testing Market, By Diagnostic Test Type Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Zika Virus Testing Market, By End User Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Zika Virus Testing Market, by 2020-2030
Figure 5.3 Leading Country/Regional Zika Virus Testing Market Share, by 2020
Figure 5.4 Leading Country/Regional Zika Virus Testing Market Share, by 2025
Figure 5.5 Leading Country/Regional Zika Virus Testing Market Share, by 2030
Figure 5.6 Europe Zika Virus Testing Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Zika Virus Testing Market, by Forecast 2020-2030
Figure 5.8 Europe Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
Figure 5.9 Europe Zika Virus Testing Submarket , By End User Forecast 2020-2030
Figure 5.10 Europe Zika Virus Testing Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Zika Virus Testing Submarket , By 2020-2030 ($billion, AGR%)
Figure 5.10 North America Zika Virus Testing Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Zika Virus Testing Market, by Forecast 2020-2030
Figure 5.12 North America Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
Figure 5.13 North America Zika Virus Testing Submarket , By End User Forecast 2020-2030
Figure 5.14 North America Zika Virus Testing Submarket , By Forecast 2020-2030
Figure 5.13 North America Zika Virus Testing Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Zika Virus Testing Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Zika Virus Testing Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
Figure 5.17 Asia-Pacific Zika Virus Testing Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Zika Virus Testing Submarket , By Forecast 2020-2030
Figure 5.18 Rest of World Zika Virus Testing Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Zika Virus Testing Market, by Forecast 2020-2030
Figure 5.20 Rest of World Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030
Figure 5.21 Rest of World Zika Virus Testing Submarket , By End User Forecast 2020-2030
Figure 5.21 Rest of World Zika Virus Testing Submarket , By Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Primerdesign Ltd Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Quest Diagnostics Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 ARUP Laboratories Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 ARUP Laboratories Revenue % Share, by Segment, 2019
Figure 6.8 ARUP Laboratories Revenue % Share, by Geographical Trade, 2019
Figure 6.9 ARUP Laboratories Revenue % Share, by Business Segment, 2019
Figure 6.10 Altona Diagnostics GmbH Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Chembio Diagnostic Systems Inc. Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 F. Hoffmann-La Roche Ltd Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 F. Hoffmann-La Roche Ltd Revenue % Share, by Regional Segment, 2019
Figure 6.14 Fast Track Diagnostics Ltd Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Fast Track Diagnostics Ltd Revenue % Share, by Regional Segment, 2019
Figure 6.16 Fast Track Diagnostics Ltd Revenue % Share, by Business Segment, 2019
Figure 6.17 Genekam Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Simens Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Simens Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Simens Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Zika Virus Testing Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Zika Virus Testing Submarket, By Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Zika Virus Testing Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Zika Virus Testing Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Zika Virus Testing Submarket, By End User Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Zika Virus Testing Market Submarket, By Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Zika Virus Testing Submarket, By End User Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Zika Virus Testing Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Zika Virus Testing Submarket, By End User Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Zika Virus Testing Market Submarket, By Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Zika Virus Testing Submarket, By Diagnostic Test Type Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Zika Virus Testing Submarket, By End User Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Primerdesign Ltd Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Primerdesign Ltd Products and Services (Product/Service, Segment)
Table 6.8 Primerdesign Ltd Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Primerdesign Ltd Total Company Recent Development 2015-2019
Table 6.10 Quest Diagnostics Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Quest Diagnostics Products and Services (Product/Service, Segment)
Table 6.12 Quest Diagnostics Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Quest Diagnostics Total Company Recent Development 2015-2019
Table 6.14 ARUP Laboratories Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 ARUP Laboratories Products and Services (Product/Service, Segment)
Table 6.16 ARUP Laboratories Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 ARUP Laboratories Total Company Recent Development 2015-2019
Table 6.18 Altona Diagnostics GmbH Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Altona Diagnostics GmbH Products and Services (Product/Service, Segment)
Table 6.20 Altona Diagnostics GmbH Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Altona Diagnostics GmbH Total Company Recent Development 2015-2019
Table 6.22 Chembio Diagnostic Systems Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Chembio Diagnostic Systems Inc. Products and Services (Product/Service, Segment)
Table 6.24 Chembio Diagnostic Systems Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Chembio Diagnostic Systems Inc. Total Company Recent Development 2015-2019
Table 6.26 F. Hoffmann-La Roche Ltd Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 F. Hoffmann-La Roche Ltd Products and Services (Product/Service, Segment)
Table 6.28 F. Hoffmann-La Roche Ltd Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 F. Hoffmann-La Roche Ltd Total Company Recent Development 2015-2019
Table 6.30 Fast Track Diagnostics Ltd Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Fast Track Diagnostics Ltd Products and Services (Product/Service, Segment)
Table 6.32 Fast Track Diagnostics Ltd Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Fast Track Diagnostics Ltd Total Company Recent Development 2015-2019
Table 6.34 Genekam Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Genekam Products and Services (Product/Service, Segment)
Table 6.36 Genekam Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Genekam Total Company Recent Development 2015-2019
Table 6.38 Simens Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Simens Products and Services (Product/Service, Segment)
Table 6.40 Simens Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Simens Total Company Recent Development 2015-2019
Top Companies
Abbott Molecular
Altona Diagnostics GmbH
ARUP Laboratories
Chembio Diagnostic Systems Inc.
F. Hoffmann-La Roche Ltd
Fast Track Diagnostics Ltd
Genekam
Luminex Corporation
Primerdesign Ltd
Quest Diagnostics
Simens
Other Companies
Aalto Bio Reagents
Artron Laboratories Inc
Biocan Diagnostics Inc
Cerus Corporation
Creative Diagnostics
ELITechGroup
EUROIMMUN US
Genbody Inc
GeneOne Life Science
GlaxoSmithKline
Hologic
InBios International
Inovio
Intrexon Corporation
Jaj International Inc
Lumiquick Diagnostics Inc
Molecular Diagnostics
Neclife
Rapigen Inc
Roche
Royal Caribbean Cruises
Sanofi
Swiss
Vela Diagnostics
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
